Clinical efficacy of Silybum marianum seed extract in treatment of type 2 diabetes mellitus and non-alcoholic fatty liver disease: a narrative review

Authors

  • Mojtaba Ziaee Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  • Saeed kianbakht Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran
  • Shamsali Rezazadeh Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran
Abstract:

Background: Several clinical studies have been undertaken to investigate the potential therapeutic effects of Silybum marianum (S. marianum) seed extract (silymarin) in Type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD). Objective: We performed the present narrative review to evaluate the efficacy of silymarin supplement for treatment of T2DM and NAFLD. Methods: Electronic databases PubMed, Science Direct, Scopus, Google and Google Scholar were surveyed for the English and non-English human clinical trial papers published concerning the effects of silymarin on T2DM and NAFLD from January 2010 to April 2018. Results: Sixteen articles regarding silymarin effects on T2DM and NAFLD in clinical studies have been included in this review. The anti-diabetic effect of silymarin was reported in four clinical trials in single formula and in one trial in combination with nettle and boswellia gum resin. The efficacy of silymarin or silybin has been reported in the treatment of NAFLD in eleven clinical trials as single formula or in combination with phosphatidylcholine, simvastatin and vitamin E. Conclusion: Silymarin appears to be effective as an adjuvant with the standard therapy in the treatment of T2DM and NAFLD.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

The Efficacy of Silymarin and Vitamin E in Non-Alcoholic Fatty Liver Disease: A Clinical Trial

Abstract Objective: Nowadays, lifestyle modification is the best treatment recommended to patients with the nonalcoholic fatty liver disease (NAFLD). The therapeutic effects of vitamin E and silybin on liver functions were documented. The present study was conducted to examine the effect of silymarin and vitamin E on patients with NAFLD. Materials and Methods: From September 2014 to March 201...

full text

Type 2 diabetes mellitus and non-alcoholic fatty liver disease: a systematic review and meta-analysis

Aim The aim of this study was the evaluation of the prevalence of NAFLD in patients with type 2 diabetes mellitus. Background Non-alcoholic fatty liver disease (NAFLD) is an emerging disease with high prevalence in patients with type 2 diabetes mellitus (T2DM). Many studies have reported the prevalence of NAFLD in type 2 diabetes mellitus patients. However, these results are inconsistent. M...

full text

Clinical Manifestations and Diagnosis of Non-Alcoholic Fatty Liver Disease

Background & Objective: Nonalcoholic fatty liver diseases (NAFLD) is the major cause of hepatocellular carcinoma and increases the risk of mortality. Understanding the trends of its clinical and biochemical changes is essential to identify patients with NAFLD that are at the greatest risk of nonalcoholic steatohepatitis (NASH) and cirrhosis in Iran. M...

full text

“study on Non Alcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus with Clinical Correlation’’

BACKGROUND Diabetes Mellitus (DM) can alter hepatic morphology and physiology 1 . Recently liver disease has been recognized as a major complication of type 2 diabetes mellitus (T2 DM). There is high prevalence of Nonalcoholic fatty liver disease (NAFLD) in individuals with T2 DM. Obesity is also a common and well documented risk factor for NAFLD. There is an epidemic rise in T2 DM, obesity, an...

full text

Impact of Co-Morbidities in Non Alcoholic Fatty Liver Disease among Type 2 Diabetes Mellitus

Non-alcoholic liver disease(NAFLD) is a common liver disorder which is closely associated with insulin resistance and type 2 diabetes mellitus and it is characterised by fat accumulation in the liver.The prevalence in diabetic population is found to be 20-40%. Studies have shown that NAFLD is strongly associated with severalmetabolic disordersand diseases, such as obesity, type 2 diabetes melli...

full text

Prevalence of non alcoholic fatty liver disease in type-2 diabetes mellitus.

Diffuse accumulation of fat in hepatocytes, occurring in individuals without a significant history of alcohol consumption is termed as Non-Alcoholic Fatty liver disease (NAFLD). It is a common condition, in which diabetic fatty liver accounts for a larger proportion. As a result of epidemic increase in diabetes mellitus, hypertension, obesity and hyperlipidemia, the prevalence of NAFLD is incre...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 1  issue 73

pages  12- 26

publication date 2020-03

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023